Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 8/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 8/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.54 |
| ▸ | CLK4 | Q9HAZ1 | 5/20 | 0.54 |
| ▸ | TSHR | P16473 | 5/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | GLA | P06280 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.50 |
| ▸ | TP53 | P04637 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | PDE5A | O76074 | 4/20 | 0.49 |
| ▸ | MAPT | P10636 | 4/20 | 0.49 |
| ▸ | USP2 | O75604 | 4/20 | 0.49 |
| ▸ | LMNA | P02545 | 4/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30757381 | 1.00 | CYP1A2 (0.54) | CYP1A2CYP3A4ALDH1A1CLK4TSHR | |
| SCHEMBL30757521 | 0.93 | CYP1A2 (0.54) | CYP1A2CYP3A4ALDH1A1CLK4TSHR | |
| SCHEMBL20954063 | 0.93 | CYP1A2 (0.54) | CYP1A2CYP3A4ALDH1A1CLK4TSHR | |
| SCHEMBL30757455 | 0.89 | CYP1A2 (0.50) | CYP1A2CYP3A4ALDH1A1CLK4TSHR | |
| SCHEMBL20954052 | 0.89 | CYP1A2 (0.50) | CYP1A2CYP3A4ALDH1A1CLK4TSHR | |
| SCHEMBL20010147 | 0.89 | CYP3A4 (0.47) | CYP1A2CYP3A4ALDH1A1CLK4TSHR | |
| SCHEMBL26467437 | 0.88 | ALDH1A1 (0.52) | CYP1A2CYP3A4ALDH1A1CLK4TSHR | |
| SCHEMBL20010030 | 0.87 | CYP19A1 (0.47) | CYP1A2CYP3A4ALDH1A1CLK4TSHR | |
| SCHEMBL18623332 | 0.85 | CYP19A1 (0.54) | CYP1A2CYP3A4ALDH1A1CLK4TSHR | |
| SCHEMBL24662771 | 0.85 | CYP2A6 (0.58) | CYP1A2CYP3A4ALDH1A1CLK4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12035622-B2 | Triazine compound and organic semiconductng layer comprising the same | NOVALED GMBH (DE) | 2024-07-09 | — | — | US | disclosed |
| US-12035622-B2 | Triazine compound and organic semiconductng layer comprising the same | NOVALED GMBH (DE) | 2024-07-09 | — | — | US | disclosed |
| CN-118102838-A | Triazine compound and organic semiconductor layer comprising the same | 诺瓦尔德股份有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-111448188-B | Triazine compound and organic semiconductor layer comprising the same | 诺瓦尔德股份有限公司 | 2024-02-13 | — | — | CN | disclosed |
| EP-3786159-B1 | TRIAZINE COMPOUND AND ORGANIC SEMICONDUCTING LAYER COMPRISING THE SAME | NOVALED GMBH (DE) | 2023-11-01 | — | — | EP | disclosed |
| EP-3786159-B1 | TRIAZINE COMPOUND AND ORGANIC SEMICONDUCTING LAYER COMPRISING THE SAME | NOVALED GMBH (DE) | 2023-11-01 | — | — | EP | disclosed |
| EP-3786159-A1 | TRIAZINE COMPOUND AND ORGANIC SEMICONDUCTING LAYER COMPRISING THE SAME | Novaled GmbH (DE) | 2021-03-03 | — | — | EP | disclosed |
| EP-3480192-B1 | TRIAZINE COMPOUND AND ORGANIC SEMICONDUCTING LAYER COMPRISING THE SAME | NOVALED GMBH (DE) | 2020-12-23 | — | — | EP | disclosed |
| EP-3480192-B1 | TRIAZINE COMPOUND AND ORGANIC SEMICONDUCTING LAYER COMPRISING THE SAME | NOVALED GMBH (DE) | 2020-12-23 | — | — | EP | disclosed |
| US-20200365810-A1 | Triazine Compound and Organic Semiconductng Layer Comprising the Same | NOVALED GMBH (DE) | 2020-11-19 | — | — | US | disclosed |
| US-20200365810-A1 | Triazine Compound and Organic Semiconductng Layer Comprising the Same | NOVALED GMBH (DE) | 2020-11-19 | — | — | US | disclosed |
| CN-111448188-A | Triazine compound and organic semiconductor layer containing the same | 诺瓦尔德股份有限公司 | 2020-07-24 | — | — | CN | disclosed |
| EP-3480192-A1 | TRIAZINE COMPOUND AND ORGANIC SEMICONDUCTING LAYER COMPRISING THE SAME | Novaled GmbH (DE) | 2019-05-08 | — | — | EP | disclosed |
| EP-3480192-A1 | TRIAZINE COMPOUND AND ORGANIC SEMICONDUCTING LAYER COMPRISING THE SAME | Novaled GmbH (DE) | 2019-05-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12035622-B2 | Triazine compound and organic semiconductng layer comprising the same | POU5F1, TERT, POU2F1 | CYP1A2 30/4885CYP3A4 113/4885ALDH1A1 628/4885 |
| US-20200365810-A1 | Triazine Compound and Organic Semiconductng Layer Comprising the Same | POU5F1, TERT, POU2F1 | CYP1A2 30/4885CYP3A4 113/4885ALDH1A1 628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.